Polio vaccine developed using tobacco plants could transform how vaccines are made

Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.

Credit: nnattalli/Shutterstock.com

Researchers from the John Innes Center in Norfolk believe their approach, which they refer to as quick, easy and cheap, could not only eliminate polio, but could be used to react to other potential threats in the future such as Ebola or Zika virus.

To create the vaccine, the researchers took the genetic code that is used to make the surface of poliovirus and added genetic material from viruses that infect plants. The new genes were then placed in soil bacteria, which infiltrated tobacco plants. The host plant read the new instructions and made large quantities of virus-like particles (VLPs) using its own protein expression mechanisms.

VLPs look almost identical to original viruses, but they are not infectious because they do not contain the nucleic acid needed for viruses to replicate. The immune system is stimulated by the virus and “trained” to respond to it, without an infection developing.

The team mixed the infected leaves with water, extracted the VLPs and administered them to animals, which then demonstrated immunity to polio.

Experts are calling the approach impressive and important.

This is an incredible collaboration involving plant science, animal virology and structural biology. The question for us now is how to scale it up - we don't want to stop at a lab technique,"

George Lomonossoff, the John Innes Center

The World Health Organisation (WHO) funded the breakthrough; it is trying to find alternatives to the live attenuated virus that is currently used for polio vaccines because live viruses carry the risk of escaping and reintroducing the disease.

Denis Murphy, a biotechnology professor from the University of South Wales refers to the current development as an important achievement. The challenge now, he says, is “to optimise the plant expression system and to move towards clinical trials of the new vaccine."

Lomonossoff says he hopes vaccines will be produced in plants in the not too distant future: "The beauty of this system of growing non-pathogenic virus mimics in plants, is that it boosts our ability to scale-up the production of vaccine candidates to combat emerging threats to human health.”

Sources

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Polio vaccine developed using tobacco plants could transform how vaccines are made. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20170816/Polio-vaccine-developed-using-tobacco-plants-could-transform-how-vaccines-are-made.aspx.

  • MLA

    Robertson, Sally. "Polio vaccine developed using tobacco plants could transform how vaccines are made". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20170816/Polio-vaccine-developed-using-tobacco-plants-could-transform-how-vaccines-are-made.aspx>.

  • Chicago

    Robertson, Sally. "Polio vaccine developed using tobacco plants could transform how vaccines are made". News-Medical. https://www.news-medical.net/news/20170816/Polio-vaccine-developed-using-tobacco-plants-could-transform-how-vaccines-are-made.aspx. (accessed November 24, 2024).

  • Harvard

    Robertson, Sally. 2018. Polio vaccine developed using tobacco plants could transform how vaccines are made. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20170816/Polio-vaccine-developed-using-tobacco-plants-could-transform-how-vaccines-are-made.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose